TY - JOUR
T1 - Dynamic interactions of a conserved enterotoxigenic Escherichia coli adhesin with intestinal mucins govern epithelium engagement and toxin delivery
AU - Kumar, Pardeep
AU - Kuhlmann, F. Matthew
AU - Bhullar, Kirandeep
AU - Yang, Hyungjun
AU - Vallance, Bruce A.
AU - Xia, Lijun
AU - Luo, Qingwei
AU - Fleckenstein, James M.
N1 - Funding Information:
LT was kindly provided by John Clements of Tulane University. This work was supported by funding from the Department of Veterans Affairs (5I01BX001469-04), grants 2R01AI89894 and 1R01AI126887-01 (J.M.F.), as well as funding from the Canadian Institute of Health Research (CIHR) and Natural Sciences and Engineering Research Council (NSERC) to B.A.V. Funding was also received from the Washington University DDRCC (NIDDK P30 DK052574) from the National Institutes of Health. K.B. was funded by a Vanier Canada Graduate Scholarship, and B.A.V. is the Children with Intestinal and Liver Disorders (CHILD) Foundation Research Chair in Pediatric Gastroenterology. The contents of this report are solely the responsibility of the authors and do not necessarily represent the official views of the NIAID, NIH, NIDDK, or VA. This work, including the efforts of James M. Fleckenstein, was funded by HHS|NIH| National Institute of Allergy and Infectious Diseases (NIAID) (2R01AI89894 and 1R01AI126887). This work, including the efforts of James M. Fleckenstein, was funded by U.S. Department of Veterans Affairs (VA) (5I01BX001469). This work, including the efforts of James M. Fleckenstein, was funded by HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (P30 DK052574). This work, including the efforts of Bruce A. Vallance, was funded by Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC). This work, including the efforts of Bruce A. Vallance, was funded by Gouvernement du Canada | Canadian Institutes of Health Research (CIHR). This work, including the efforts of Lijun Xia, was funded by HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5R01DK085691).
Publisher Copyright:
© 2016, American Society for Microbiology. All Rights Reserved.
PY - 2016
Y1 - 2016
N2 - At present, there is no vaccine for enterotoxigenic Escherichia coli (ETEC), an important cause of diarrheal illness. Nevertheless, recent microbial pathogenesis studies have identified a number of molecules produced by ETEC that contribute to its virulence and are novel antigenic targets to complement canonical vaccine approaches. EtpA is a secreted two-partner adhesin that is conserved within the ETEC pathovar. EtpA interacts with the tips of ETEC flagella to promote bacterial adhesion, toxin delivery, and intestinal colonization by forming molecular bridges between the bacteria and the epithelial surface. However, the nature of EtpA interactions with the intestinal epithelium remains poorly defined. Here, we demonstrate that EtpA interacts with glycans presented by transmembrane and secreted intestinal mucins at epithelial surfaces to facilitate pathogen-host interactions that culminate in toxin delivery. Moreover, we found that a major effector molecule of ETEC, the heat-labile enterotoxin (LT), may enhance these interactions by stimulating the production of the gel-forming mucin MUC2. Our studies suggest, however, that EtpA participates in complex and dynamic interactions between ETEC and the gastrointestinal mucosae in which host glycoproteins promote bacterial attachment while simultaneously limiting the epithelial engagement required for effective toxin delivery. Collectively, these data provide additional insight into the intricate nature of ETEC interactions with the intestinal epithelium that have potential implications for rational approaches to vaccine design.
AB - At present, there is no vaccine for enterotoxigenic Escherichia coli (ETEC), an important cause of diarrheal illness. Nevertheless, recent microbial pathogenesis studies have identified a number of molecules produced by ETEC that contribute to its virulence and are novel antigenic targets to complement canonical vaccine approaches. EtpA is a secreted two-partner adhesin that is conserved within the ETEC pathovar. EtpA interacts with the tips of ETEC flagella to promote bacterial adhesion, toxin delivery, and intestinal colonization by forming molecular bridges between the bacteria and the epithelial surface. However, the nature of EtpA interactions with the intestinal epithelium remains poorly defined. Here, we demonstrate that EtpA interacts with glycans presented by transmembrane and secreted intestinal mucins at epithelial surfaces to facilitate pathogen-host interactions that culminate in toxin delivery. Moreover, we found that a major effector molecule of ETEC, the heat-labile enterotoxin (LT), may enhance these interactions by stimulating the production of the gel-forming mucin MUC2. Our studies suggest, however, that EtpA participates in complex and dynamic interactions between ETEC and the gastrointestinal mucosae in which host glycoproteins promote bacterial attachment while simultaneously limiting the epithelial engagement required for effective toxin delivery. Collectively, these data provide additional insight into the intricate nature of ETEC interactions with the intestinal epithelium that have potential implications for rational approaches to vaccine design.
UR - http://www.scopus.com/inward/record.url?scp=85002836374&partnerID=8YFLogxK
U2 - 10.1128/IAI.00692-16
DO - 10.1128/IAI.00692-16
M3 - Article
C2 - 27736776
AN - SCOPUS:85002836374
SN - 0019-9567
VL - 84
SP - 3608
EP - 3617
JO - Infection and Immunity
JF - Infection and Immunity
IS - 12
ER -